> ## Content Index
> Fetch the complete content index at: https://nordisk-ai.ghost.io/llms.txt
> Use this file to discover other available public pages before exploring further.

# AI-Developed Drugs Are on Their Way to Becoming Reality
- URL: https://nordisk-ai.ghost.io/ai-developed-drugs-are-on-their-way-to-becoming-reality/
- Published: 2025-02-18T08:07:03.000Z
- Updated: 2026-08-27T15:06:15.000Z
- Description: AI is driving a revolution in drug development - the first AI-developed drugs could start being tested as soon as this year. How fast could this change healthcare?
- Author: Anders Hagen
- Tags: Society and Politics, AI, aisweden, artificial intelligence, Demis Hassabis, Isomorphic Labs, drug development, The Nobel Prize, nordiskai, #Migrated-1787841634512, #wp, #wp-post, #Import 2026-08-27 14:41, #Import 2026-09-07 13:41

Four years ago, Alphabet's subsidiary Isomorphic Labs took a big step toward using artificial intelligence to create cheaper, more effective drugs. Now founder Demis Hassabis says the first AI-developed drugs could start being tested as early as the end of the year.

#### Shorter Time From Research to Finished Drug

Traditionally, it takes between five and ten years to develop a new drug, but with the help of AI, the process could be drastically shortened. According to Hassabis, development could go up to ten times faster, which would mean a revolution in healthcare.

\- If we succeed with this, it could have a huge impact on people's health, says Demis Hassabis in an interview with the Financial Times.

#### Partnerships With Major Pharmaceutical Companies

To realize his vision, Isomorphic Labs has established partnerships with several leading pharmaceutical companies, including Eli Lilly and Novartis. This means AI-developed drugs could reach the market faster once testing is complete.

#### Nobel Prize for Groundbreaking AI Work

Demis Hassabis, who recently received the Nobel Prize in Chemistry, is a central figure in this development. The prize was shared with David Baker and John M. Jumper for their work in protein structure prediction, a technology that's also crucial for AI-driven drug development.